Características metabólicas de los pacientes con apneas obstructivas del sueño
DOI:
https://doi.org/10.47196/diab.v54i1.176Palabras clave:
síndrome metabólico, apneas obstructivas del sueño, obesidadResumen
Introducción: la apnea obstructiva del sueño (AOS) es una patología de alta prevalencia asociada al sobrepeso y la obesidad. La relación entre el síndrome metabólico (SM) y la AOS no ha sido comunicada en nuestro medio.
Materiales y métodos: estudio retrospectivo en adultos seleccionados para poligrafía respiratoria y evaluación metabólica clasificados según la presencia de SM.
Resultados: incluimos 302 pacientes. La prevalencia de obesidad fue de 66,88% y de SM de 62,58%. El 19% presentó síntomas de somnolencia diurna y el 48,3% mostró cinco o más componentes del cuestionario STOP-BANG.
Los pacientes con AOS fueron mayormente del sexo masculino, con mayor edad; peso corporal, circunferencia de cintura y cuello comparados con el grupo sin AOS (57 vs 49 años, p<0,001; 93,89 vs 85 kg, p<0,05; 108 vs 100 cm, p<0,001 respectivamente). Mostraron mayores valores de triglicéridos, presión arterial sistólica, obesidad e índice de desaturación (134 vs 99 mg/dl, p<0,001; 134 vs 128 mmHg, p<0,05; 69,2 vs 52,3%, p<0,05 y 14,6 vs 2 ev/h, p<0,001 respectivamente). La cantidad de componentes de STOP-BANG fue mayor en los pacientes con AOS (5 vs 3; p<0,001).
Conclusiones: AOS y SM están frecuentemente relacionados y permanecen subdiagnosticados. La utilización de cuestionarios validados facilita la identificación de candidatos a estudios de sueño. Se necesita la implementación de programas de gestión de hábitos saludables para prevenir las complicaciones de ambas patologías.
Citas
I. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle aged adults. N Engl J Med 1993; 328: 1230-5.
II. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010; 11(5):441-6.
III. Aggi HK, Strohl KP. Adult obstructive sleep apnea/hypopnea syndrome: definitions, risk factors, and pathogenesis.Clin Chest Med 2010; 31(2):179-186.
IV. Cuarta Encuesta Nacional de Factores de Riesgo 2019. Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000001444cnt-4ta-encuesta-nacional-factores-riesgo_2019_principales-resultados.pdf.
V. Xu HJ, Lan XF, Li QY, et al. Factors affecting blood pressure profile in pre and postmenopausal women with obstructive sleep apnea hypopnea syndrome. Sleep and Breathing 2015; 19(1):169-174.
VI. Epstein LJ, Kristo D, Strollo PJ, et al. Adult obstructive sleep apnea task force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine: JCSM: official publication of the American Academy of Sleep Medicine 2009; 5(3):263-76.
VII. Nogueira F, Nigro C, Cambursano H, Borsini E, Silio J, Avila J. Practical guidelines for the diagnosis and treatment of obstructive sleep apnea syndrome. Medicina (B Aires) 2013;73(4):349-62.
VIII. Borsini E, Salvado A, Bosio M, Khoury M, Decima T, Quadrelli S, Ernst G, Chertcoff J. Utilidad de los componentes del cuestionario Stop-Bang para identificar pacientes con apneas del sueño. RAMR 2014; 4:382-403.
IX. Chiner E, Arriero JM, Signes-Costa J, Marco J, Fuentes I. Validation of the Spanish version of the epworth sleepiness scale in patients with a sleep apnea syndrome. Arch Bronconeumol 1999; 35:422-427.
X. Borsini E, Blanco M, Schonfeld S, Ernst G, Salvado A. Performance of epworth sleepiness scale and tiredness symptom used with simplified diagnostic tests for the identification of sleep apnea. Sleep Sci 2019; ahead of print. Doi: 10.5935/1984-0063.20190095
XI. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 20;120(16):1640-1645. doi: 10.1161/circulationaha.109.192644.
XII. Silva V, Stanton KR, Grande AJ. Harmonizing the diagnosis of metabolic syndrome focusing on abdominal obesity. Metab Syndr Relat Disord 2013; 11(2):102-108. Doi: 10.1089/met.2012.0060.
XIII. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53(4):600-605. Doi: 10.1007/s00125-009-1620-4.
XIV. Bonsignore MR, Esquinas C, Barceló A, Sánchez de la Torre M, Paternó A, Duran-Cantolla J, Marín JM, Barbé F. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 2012; 39(5):1136-1143. Doi: 10.1183/09031936.00151110.
XV. Shayestefar M, Sadeghniiat Haghighi K, Jahanfar S, Delvarianzadeh M, Nematzadeh F, Ebrahimi MH. Assessment of the relationship between metabolic syndrome and obstructive sleep apnea in male drivers of Shahroud city in 2018: a cross sectional study. BMC Public Health 2019;19(1):1058. Doi: 10.1186/s12889-019-7361-5.
XVI. Kong DL, Qin Z, Wang W, Pan Y, Kang J, Pang J. Association between obstructive sleep apnea and metabolic syndrome: a meta-analysis. Clin Invest Med 2016; 39(5):E161-E172.
XVII. Chiner E, Arriero JM, Signes-Costa J, Marco J, Fuentes I (validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome). Arch Bronconeumol 1999; 35(9):422-427.
XVIII. Borsini E, Ernst G, Salvado A, Bosio M, Chertcoff J, Nogueira F, Nigro C (2015). Utility of the STOP-BANG components to identify sleep apnea using home respiratory polygraphy. Sleep Breath. 1999;19(4):1327-1333. Doi: 10.1007/s11325-015-1174-2.
XIX. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, Hudgel D, Sateia M, Schwab R; Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007 Dec 15; 3(7):737-47.
XX. 20.World Health Organization. Obesity: preventing and managing the global epidemic. Technical Report Series 894, 2000; page 1. Disponible en: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/.
XXI. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
XXII. Borsini E, Blanco M, Bosio M, Schrappe M, Ernst G, Nosetto D, Gaggioli N, Salvado A, Manuale O, Schiavone M. Prevalence of sleep apnea and cardiovascular risk factors in patients with hypertension in a day hospital model. Clin Exp Hypertens 2017 Sep; 5:1-7.
XXIII. Ernst G, Bosio M, Salvado A, Dibur E, Nigro C, Borsini E. Difference between apnea-hypopnea index (AHI) and oxygen desaturation index (ODI): proportional increase associated with degree of obesity. Sleep Breath 2016; 20(4):1175-1183. Doi: 10.1007/s11325-016-1330-3.
XXIV. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011; 58(5):811-17.
XXV. Schiavone M, Ernst G, Blanco M, Avaca H, Acosta AL, Nosetto D, Manuale O, Salvado A, Borsini E. Performance of questionnaires aimed at detecting sleep disorders in patients attending a hypertension center. Clin Exp Hypertens 2019; 41(7):687-691. Doi: 10.1080/10641963.2018.1539095. Epub 2018 Nov 29.
XXVI. Ramachandran SK, Josephs LA. A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 2009; 110:928-39.
XXVII. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anaesth 2010; 57:423-38.
XXVIII. Dobrosielski DA, Papandreou C, Patil SP, Salas-Salvadó J. Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk. Eur Respir Rev 2017; 26(144). pii: 160110. Doi: 10.1183/16000617.0110-2016.
XXIX. Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M; Kuopio Sleep Apnea Group. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 2009; 179(4):320-7. Doi: 10.1164/rccm.200805-669OC.
XXX. Papandreou C, Schiza SE, Bouloukaki I, Hatzis CM, Kafatos AG, Siafakas NM, Tzanakis NE. Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J 2012; 39(6):1398-404. Doi: 10.1183/09031936.00103411.
XXXI. Nogueira F, Nigro C, Cambursano H, Borsini E, Silio J, Avila J. Practical guidelines for the diagnosis and treatment of obstructive sleep apnea syndrome. Medicina (B Aires). 2013; 73(4):349-62.
XXXII. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676. Doi: 10.1164/ajrccm.165.5.2103001.
XXXIII. Ryan S. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol 2017; 595: 2423-2430. Doi: 10.1113/JP273312.
XXXIV. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741.
XXXV. Sasanabe R, Banno K, Otake K, Hasegawa R, Usui K, Morita M, Shiomi T. Síndrome metabólico en pacientes japoneses con síndrome de apnea obstructiva del sueño. Hypertens Res Mayo de 2006; 29 (5): 315-22.
XXXVI. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007 Aug 15; 3(5):467-72.
XXXVII. Akahoshi T, Uematsu A, Akashiba T, Nagaoka K, Kiyofuji K, Kawahara S, Hattori T, Kaneita Y, Yoshizawa T, Takahashi N, Uchiyama M, Hashimoto S. Respirology. obstructive sleep apnoea is associated with risk factors comprising the metabolic syndrome. Respirology 2010;15(7):1122-6. doi: 10.1111/j.1440-1843.2010.01818.x.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
